BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18375318)

  • 1. Postoperative treatment with angiotensin-converting enzyme inhibitors in patients with preoperative reduced left ventricular systolic function.
    Villacorta J; Oddoze C; Giorgi R; Kerbaul F; Bonnet M; Collart F; Gouin F; Guidon C
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):187-91. PubMed ID: 18375318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral thyroid hormone pretreatment in left ventricular dysfunction.
    Sirlak M; Yazicioglu L; Inan MB; Eryilmaz S; Tasoz R; Aral A; Ozyurda U
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):720-5. PubMed ID: 15450562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is administration of preoperative angiotensin-converting enzyme inhibitors important for renal protection after cardiac surgery?
    Dag O; Kaygin MA; Aydin A; Limandal HK; Arslan Ü; Kiymaz A; Kahraman N; Calik ES; Erkut B
    Ren Fail; 2013; 35(5):754-60. PubMed ID: 23521631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.
    Cardinale D; Colombo A; Sandri MT; Lamantia G; Colombo N; Civelli M; Martinelli G; Veglia F; Fiorentini C; Cipolla CM
    Circulation; 2006 Dec; 114(23):2474-81. PubMed ID: 17101852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
    Bart BA; Ertl G; Held P; Kuch J; Maggioni AP; McMurray J; Michelson EL; Rouleau JL; Warner Stevenson L; Swedberg K; Young JB; Yusuf S; Sellers MA; Granger CB; Califf RM; Pfeffer MA
    Eur Heart J; 1999 Aug; 20(16):1182-90. PubMed ID: 10448027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Roy P; Bouchard J; Amyot R; Madore F
    Am J Kidney Dis; 2006 Oct; 48(4):645-51. PubMed ID: 16997061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
    Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
    Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
    Duboc D; Meune C; Lerebours G; Devaux JY; Vaksmann G; Bécane HM
    J Am Coll Cardiol; 2005 Mar; 45(6):855-7. PubMed ID: 15766818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflurane, 0.5 minimum alveolar concentration administered through the precardiopulmonary bypass period, reduces postoperative dobutamine requirements of cardiac surgery patients: a randomized study.
    Ndoko SK; Tual L; Ait Mamar B; Sauvat S; Jabre P; Zakhouri M; Rosanval O; Abdi M; Kirsch M; Pouzet B; Loisance D; Dhonneur G
    J Cardiothorac Vasc Anesth; 2007 Oct; 21(5):683-9. PubMed ID: 17905274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery.
    Rady MY; Ryan T
    Chest; 1998 Aug; 114(2):487-94. PubMed ID: 9726735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
    Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
    Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACE inhibitors in the treatment of ventricular dysfunction caused by cardiotoxic cytostatics].
    Mladosievicová B
    Ceska Slov Farm; 2004 Mar; 53(2):55-60. PubMed ID: 15095572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations.
    Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF
    Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery.
    Feringa HH; Bax JJ; Schouten O; Poldermans D
    Semin Cardiothorac Vasc Anesth; 2006 Mar; 10(1):25-31. PubMed ID: 16703231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.